Latest Regulatory News

Lunnon Metals reports significant high-grade gold assay results from the Lady Herial deposit, confirming promising mineralisation below and within the planned open pit. The company advances towards regulatory approvals and a final investment decision.

Fisher & Paykel Healthcare has updated its dividend announcement to include the Australian Dollar equivalent, providing clearer insight for investors ahead of the mid-December payment.

Rand Mining has released a replacement exploration report for the East Kundana Joint Venture, highlighting new JORC disclosures and promising high-grade gold assay results from the Ambition prospect.

Progress 2020-1 Trust has completed the redemption of its A$920 million Class A Floating Rate Notes, leading to their suspension and removal from the ASX Official List.

Locate Technologies secures court approval to transition its holding company to a newly listed New Zealand entity, marking a significant restructuring and ASX delisting.

St Barbara Limited has completed a compelling restart study for its Touquoy gold project in Nova Scotia, outlining a low-capital, near-term operation with robust economics and a positive permitting outlook.

St Barbara Limited has locked in A$470 million in funding through strategic partnerships with Lingbao Gold Group and Kumul Mineral Holdings, fully financing the Simberi Gold Project expansion and accelerating its development timeline.

St Barbara Limited has agreed to sell a 20% interest in its Simberi Gold Project to Papua New Guinea’s Kumul Mineral Holdings for A$100 million, forming a strategic joint venture that aligns with PNG’s resource ownership goals.

St Barbara Limited’s latest Feasibility Study confirms the Simberi Expansion Project as a long-life, low-cost gold and silver operation with robust economics and a 13-year mine life. The project promises over 2 million ounces of gold production and competitive costs, pending key regulatory approvals.

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

InhaleRx advances its clinical pipeline with a new oral treatment for resistant depression and plans a strategic rebrand to Nexalis Therapeutics, signaling a broader focus beyond inhaled therapies.

Anax Metals has completed a $2.4 million strategic placement by issuing over 219 million shares to Gold Valley Pilbara, strengthening its capital base. The placement was executed under existing capacity and accompanied by a cleansing notice confirming regulatory compliance.